| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 708854 | Null | 0.0228506033927954 | 0.29630774 |
| NSC 711741 | Di-(1,3-dibromo-4-oxo-5,6-dihydro-4H-cyclopenta[c]thien-6-yl) amine | 0.0228506033927954 | 0.20189337 |
| NSC 718191 | Null | 0.0228506033927954 | 0.36284191 |
| NSC 724771 | Null | 0.0228506033927954 | -0.0094144263 |
| NSC 724827 | 1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline | 0.0228506033927954 | 0.33948947 |
| NSC 726718 | 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid | 0.0228506033927954 | 0.27905481 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.0228506033927954 | 0.080068452 |
| NSC 728512 | 1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine | 0.0228506033927954 | 0.17697193 |
| NSC 730294 | Null | 0.0228506033927954 | 0.24581061 |
| NSC 730460 | 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate | 0.0228506033927954 | 0.0030798479 |